Enter your login e-mail to the account
Search
- Pacient s roztroušenou sklerózou v současném systému
Doc. MUDr. Martin Vališ, Ph.D., MUDr. Zbyšek Pavelek, PhD.
(2/2018, Interdisciplinary consilium )
- Creutzfeldt-Jakobov disease: clinical case report
MUDr. Petr Nohel, prof. MUDr. Radoslav Matěj, Ph.D.
(1/2022, online attachment ) - Hereditary chorea with a tendency to insanity and adult onset: 150 years since George Huntington and his disease
MUDr. Ján Necpál, MUDr. Michal Patarák, PhD.
(1/2022, online attachment ) - Ethical aspects of help in families with spinal muscular atrophies
Mgr. Helena Kočová
(6/2013, From the boundary of neurology ) - Adherence to treatment in multiple sclerosis: case reports of three female patients on high-efficacy therapy with ocrelizumab
MUDr. Jana Pavlíčková, Ph.D.
(3/2024, Case reports ) - The role of B lymphocytes in the immunopathogenesis and treatment of multiple sclerosis
prof. MUDr. Ľubomír Lisý, DrSc.
(3/2024, Informations ) - Surgical treatment of tremor
MUDr. Martin Nevrlý, Ph.D., MUDr. Jan Bardoň, doc. MUDr. David Krahulík, Ph.D., MBA, MUDr. Pavel Otruba, MBA, Prof. MUDr. Petr Kaňovský, CSc., FEAN
(6/2020, Main topic ) - Psychosocial attributes of multiple sclerosis
PhDr. Dagmar Magurová, PhD., PhDr. Iveta Ondriová, PhD.
(5/2010, From the boundary of neurology ) - Trends in the occurrence of Creutzfeldt‑Jakob disease in Slovakia in the years 2007–2022
RNDr. Dana Žáková, PhD., PhDr. Martin Štelzer, MUDr. Alžbeta Janáková, Ing. Silvia Koščová, Mgr. Katarína Melicherová, Ing. Zuzana Szarvasová, MVDr. Girma Belay, CSc.
(1/2024, Main topic ) - Quality of life and quality of working life in patients with multiple sclerosis
MUDr. Eva Meluzínová, Ing. Veronika Mezerová, MUDr. Ing. Lubomír Poušek, MBA
(2/2014, Case reports )
- New disorders suitable for newborn screening in Slovakia
RNDr. Mária Knapková, PhD., MUDr. Katarína Okáľová, PhD., PhDr. Zuzana Mydlová, MUDr. Katarína Tabačáková, prof. MUDr. Svetozár Dluholucký, CSc.
(2/2020, Review articles )
- Renal carcinoma and immunotherapy
MUDr. Alexandr Poprach, Ph.D., MUDr. Radek Lakomy, Ph.D.
(2/2017, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles )
- Daratumumab across multiple myeloma treatment lines
MUDr. Juliana Holasová, Doc. MUDr. Ľubica Harvanová, PhD., MUDr. Iveta Simančíková, MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, PhD., MUDr. Emília Flochová, PhD., MUDr. Juraj Chudej, PhD., MBA, MUDr. Natália Štecová, PhD., MUDr. Tomáš Guman, PhD., MUDr. Alexander Wild, PhD.
(6/2023, Drugs & drug classes ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Waldenström’s macroglobulinemia in 2016: in order to optimize immunochemotherapy minimizing side effects
MUDr. Michal Kaščák, Mgr. Zuzaná Kufová, Mgr. Kateřina Growková, prof. MUDr. Roman Hájek, CSc.
(5/2016, Spectrum ) - Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
doc. MUDr. Martin Mistrík, PhD., doc. MUDr. Angelika Bátorová, PhD., MUDr. Ľubica Roziaková, PhD.
(3/2014, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Anthracyclines in treating metastatic breast cancer
MUDr. Katarína Petráková
(3/2014, Review articles ) - Treatment of patients with HR+, HER2- PIK3CA-mutated advanced/metastatic breast cancer: results of trial SOLAR-1
MUDr. Andrej Rosík
(2/2021, Review articles ) - Publikujeme v zahraničí
(6/2015, Information & comments ) - Spiritual care for a patient with incurable disease – is a physician´s interest necessary?
MUDr. Andrea Škripeková, PhD.
(3/2019, Special topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Systemic treatment of cancer of unknown primary origin
MUDr. Mária Rečková
(4/2013, Main topic ) - Malnutrition in cancer patients – practical and ethical issues
MUDr. Andrea Škripeková
(4/2013, Topic of the year ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - Panobinostat in treatment of multiple myeloma
MUDr. Miriam Ladická
(6/2017, Drugs & drug classes ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - Acalabrutinib, a new Bruton's tyrosine kinase inhibitor in first line CLL treatment
MUDr. Zuzana Sninská, PhD., prof. MUDr. Angelika Bátorová, PhD.
(2/2023, Review articles ) - PALLIATIVE TREATMENT IN PAEDIATRIC ONCOLOGY
MUDr. Mária Jasenková
(5/2007, Palliative care )
- Pruritus in palliative patients
MUDr. Eva Kováčová, PhD.
(3/2023, Interdisciplinary consilium )
- Spiritual care for a patient with incurable disease – is a physician´s interest necessary?
MUDr. Andrea Škripeková, PhD.
(2e/2019, Review articles ) - Opioid-induced hyperalgesia syndrome
MUDr. Zuzana Otrubová
(2e/2015, Review articles ) - Advanced heart failure management in palliative care settings
MUDr. Ladislav Kabelka, Ph.D., MUDr. Věra Havlénová
(2/2009, Review articles ) - Terminall stage in 28 years old woman
MUDr. Ladislav Kabelka, Ph.D., MUDr. Věra Havlénová
(2/2009, Original articles ) - Multidisciplinary team in palliative care at the haemato-oncology department – case study
PhDr. ThLic. Marta Hošťálková, Th.D., Ph.D., MUDr. Renata Urbanová, Ph.D., Bc. Jitka Vítková
(1-2e/2018, Original articles ) - Common neurological disorders demanding palliative care
MUDr. Hedviga Jakubíková
(1/2009, Interdisciplinary consilium ) - Subcutaneous administration of drugs and fluids in palliative medicine
MUDr. Ondřej Sláma
(2/2008, Review articles )
- History, diagnosis and experiences of patients with multiple sclerosis
Mgr. Ivana Pankuchová, MUDr. Ľubica Procházková, CSc., PharmDr. Adela Čorejová, PhD.
(3/2013, Current pharmacotherapy )
- Dural arteriovenous fistula as a cause of reversible dementia syndrome – neuroembolization therapy
MUDr. Eva Unčovská, MUDr. Zuzana Čarnická, PhD., MUDr. Samuel Hadvig, MUDr. Ivan Vulev, PhD., MPH, FCIRSE
(2/2022, Main topic )